Name: Cat eye syndrome critical region protein 2 Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Cat eye syndrome critical region protein 2 Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	(4R)-4-Methyl-6-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one	IC50	7700.0 ^[1]
	Nvs-cecr2-1	IC50	47.0 ^[1]
	4-Cyano-N-(1,3-diethyl-2-oxoquinolin-6-yl)benzenesulfonamide	IC50	20000.0 ^[1], 100000.0 ^[2]
	4-[(2s,4r)-1-Acetyl-4-[(4-Chlorophenyl)amino]-2-Methyl-1,2,3,4-Tetrahydroquinolin-6-Yl]benzoic Acid	IC50	31622.78 ^[1]
	3-[7-(Difluoromethyl)-6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-N-methyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxamide	IC50	20000.0 ^[1]
Rows per page: 1–5 of 41

References

This online resource may be cited as follows

MLA	"Quest Database™ Cat eye syndrome critical region protein 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 17 Dec. 2025, https://www.aatbio.com/data-sets/cat-eye-syndrome-critical-region-protein-2-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 17). Quest Database™ Cat eye syndrome critical region protein 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/cat-eye-syndrome-critical-region-protein-2-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan